7-benzyl-5,6,7,8-tetrahydro-2-phenylamino-4H-pyrido[4',3':4,5]thieno[2,3-d][1,3]oxazin-4-one

ID: ALA355626

Chembl Id: CHEMBL355626

PubChem CID: 11545571

Max Phase: Preclinical

Molecular Formula: C22H19N3O2S

Molecular Weight: 389.48

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1oc(Nc2ccccc2)nc2sc3c(c12)CCN(Cc1ccccc1)C3

Standard InChI:  InChI=1S/C22H19N3O2S/c26-21-19-17-11-12-25(13-15-7-3-1-4-8-15)14-18(17)28-20(19)24-22(27-21)23-16-9-5-2-6-10-16/h1-10H,11-14H2,(H,23,24)

Standard InChI Key:  NHAHPCBTIKODHT-UHFFFAOYSA-N

Associated Targets(non-human)

CEL Cholesterol esterase (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.48Molecular Weight (Monoisotopic): 389.1198AlogP: 4.55#Rotatable Bonds: 4
Polar Surface Area: 58.37Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.66CX LogP: 5.19CX LogD: 5.12
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.51

References

1. Pietsch M, Gütschow M..  (2005)  Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.,  48  (26): [PMID:16366609] [10.1021/jm0508639]

Source